BIO Releases Investment and Deal Making Study Showing Record-Breaking Year for US Venture Capital Funding of Biotech

Today, the Biotechnology Innovation Organization (BIO) released a new report - Emerging Therapeutic Company Investment and Deal Trends – highlighting ten years (2006-2015) of biotechnology funding and deal making across five areas: venture capital, IPOs, follow-on public offerings, licensing, and acquisitions. 

Top Political Experts to Discuss Presidential Election at 2016 BIO International Convention

The Honorable Newt Gingrich, Candy Crowley and Stephanie Cutter to participate on keynote panel Wednesday, June 8. A former Speaker of the House, an award winning journalist and a top political strategist will lead a spirited discussion on the 2016 presidential election and its potential impact on the biotechnology industry and the global economy at the 2016 Biotechnology Innovation Organization (BIO) Convention.

BIO Statement on EPA’s Proposed Rule for the 2017 Renewable Fuel Standards

The proposed rule for the 2017 Renewable Fuel Standard (RFS), issued today by the Environmental Protection Agency (EPA), fails to put the program fully back on track and continues to create uncertainty for advanced and cellulosic biofuel producers and their investors.

BIO Submits Comments to FDA's Draft EA and Preliminary FONSI Regarding the Proposed Field Trial of the OX513A Strain of Aedes aegypti (Ae. aegypti)

The Biotechnology Innovation Organization (BIO) appreciates this opportunity to provide comments to the U.S. Food and Drug Administration (FDA) on the draft environmental assessment (EA)1 and preliminary finding of no significant impact (FONSI) regarding the proposed field trial of the OX513A strain of Aedes aegypti (Ae. aegypti) developed by Oxitec.

NAS Report Upholds Safety of GE Crops and Foods

There’s no evidence to suggest that foods from genetically engineered (GE) crops are less safe than foods from non-GE crops, according to a new National Academies of Sciences report.

BIO Comments Re: Comments on Sharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors

Dear Dr. Taichman:


Will Smith to Deliver Keynote at 2016 BIO International Convention

Actor, producer, musician and philanthropist recently played Dr. Bennet Omalu in the film, “Concussion”

BIO’s Livestock Biotech Summit Becomes Animal Biotech Summit to Reflect New Theme and Goals

“Advancing One Health through Biotechnology”

BIO Comments on FDA Natural Food Labeling

The Biotechnology Innovation Organization (BIO) is pleased to submit these comments to FDA in response to FDA’s request for information on the use of the term “natural” on food labeling (docket no. FDA-2014-N-1207). BIO is the world's largest biotechnology trade association, representing companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than thirty other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.

BIO Submits Comments Re: Medicare Program; Part B Drug Payment Model [CMS-1670-P]

The Biotechnology Innovation Organization appreciates this opportunity to submit comments on the Centers for Medicare and Medicaid Services’ proposed rule entitled Medicare Program; Part B Drug Payment Model...